RATIONALE: Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease causing paralysis and death from respiratory failure. Strategies to preserve and/or restore respiratory function are critical for successful treatment. Although breathing capacity is maintained until late in disease progression in rodent models of familial ALS (SOD1(G93A) rats and mice), reduced numbers of phrenic motor neurons and decreased phrenic nerve activity are observed. Decreased phrenic motor output suggests imminent respiratory failure. OBJECTIVES: To preserve or restore phrenic nerve activity in SOD1(G93A) rats at disease end stage. METHODS: SOD1(G93A) rats were injected with human neural progenitor cells (hNPCs) bracketing the phrenic motor nucleus before disease onset, or exposed to acute intermittent hypoxia (AIH) at disease end stage. MEASUREMENTS AND MAIN RESULTS: The capacity to generate phrenic motor output in anesthetized rats at disease end stage was: (1) transiently restored by a single presentation of AIH; and (2) preserved ipsilateral to hNPC transplants made before disease onset. hNPC transplants improved ipsilateral phrenic motor neuron survival. CONCLUSIONS: AIH-induced respiratory plasticity and stem cell therapy have complementary translational potential to treat breathing deficits in patients with ALS.
RATIONALE: Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease causing paralysis and death from respiratory failure. Strategies to preserve and/or restore respiratory function are critical for successful treatment. Although breathing capacity is maintained until late in disease progression in rodent models of familial ALS (SOD1(G93A) rats and mice), reduced numbers of phrenic motor neurons and decreased phrenic nerve activity are observed. Decreased phrenic motor output suggests imminent respiratory failure. OBJECTIVES: To preserve or restore phrenic nerve activity in SOD1(G93A) rats at disease end stage. METHODS:SOD1(G93A) rats were injected with human neural progenitor cells (hNPCs) bracketing the phrenic motor nucleus before disease onset, or exposed to acute intermittent hypoxia (AIH) at disease end stage. MEASUREMENTS AND MAIN RESULTS: The capacity to generate phrenic motor output in anesthetized rats at disease end stage was: (1) transiently restored by a single presentation of AIH; and (2) preserved ipsilateral to hNPC transplants made before disease onset. hNPC transplants improved ipsilateral phrenic motor neuron survival. CONCLUSIONS: AIH-induced respiratory plasticity and stem cell therapy have complementary translational potential to treat breathing deficits in patients with ALS.
Authors: Nicholas M Boulis; Thais Federici; Jonathan D Glass; J Simon Lunn; Stacey A Sakowski; Eva L Feldman Journal: Nat Rev Neurol Date: 2011-12-13 Impact factor: 42.937
Authors: C N Svendsen; M A Caldwell; J Shen; M G ter Borg; A E Rosser; P Tyers; S Karmiol; S B Dunnett Journal: Exp Neurol Date: 1997-11 Impact factor: 5.330
Authors: Michael J Devinney; Daryl P Fields; Adrianne G Huxtable; Timothy J Peterson; Erica A Dale; Gordon S Mitchell Journal: J Neurosci Date: 2015-05-27 Impact factor: 6.167
Authors: Lorelei Stoica; Allison M Keeler; Lang Xiong; Michael Kalfopoulos; Kaitlyn Desrochers; Robert H Brown; Miguel Sena-Esteves; Terence R Flotte; Mai K ElMallah Journal: Am J Respir Cell Mol Biol Date: 2017-03 Impact factor: 6.914
Authors: Mai K ElMallah; Silvia Pagliardini; Sara M Turner; Anthony J Cerreta; Darin J Falk; Barry J Byrne; John J Greer; David D Fuller Journal: Am J Respir Cell Mol Biol Date: 2015-09 Impact factor: 6.914